A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/505 (2006.01) A61K 31/445 (2006.01) A61K 31/47 (2006.01) A61K 31/54 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2108480
2108480 9218127 PCTABS00016 The invention relates to a method of treating psychosis in a mammal which comprises administering to the mammal an effective amount of a dopamine receptor antagonist antipsychotic and a sigma receptor antagonist having greater affinity for sigma receptors than for dopamine receptors, in an amount effective to selectively enhance the antipsychotic effects of the dopamine receptor antagonist relative to the adverse side effects of the dopamine receptor antagonist.
Cook Leonard
Du Pont Merck Pharmaceutical Company
Sim & Mcburney
LandOfFree
Use of sigma receptor antagonists to enhance the effects of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sigma receptor antagonists to enhance the effects of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sigma receptor antagonists to enhance the effects of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2023884